StockClub

SYRE

SYRESpyre Therapeutics, Inc.$ --
Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc.

SYRE

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-46M USD
YoY +14.8%
Net Income
-69M USD
YoY -54.1%
EPS
-0.74$
YoY -469.2%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$90.5M
$90.5M
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-69M
FY2024 Q2$-82.7M
$-82.7M
Q2
FY2024 Q3$-151.7M
$-151.7M
Q3
FY2024 Q4$-208M
$-208M
Q4
FY2025 Q1$-44.8M
$-44.8M
Q1
FY2025 Q2$-81.5M
$-81.5M
Q2
FY2025 Q3$-92.7M
$-92.7M
Q3
FY2025 Q4$-155.2M
$-155.2M
Q4
FY2026 Q1$-69M
$-69M
Q1
Actual
$-24.2M (-54.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021BEAT
Actual:$18.7M
Est:$18.4M
FY2021BEAT
$18.7M
FY2022BEAT
Actual:$2.3M
Est:$2.2M
FY2022BEAT
$2.3M
FY2023BEAT
Actual:$886,000
Est:$688,000
FY2023BEAT
$886,000
FY2024MISS
Actual:$0
Est:$2.6M
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$88,600
FY2025MISS
$0

Analyst Estimates